Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Prescription Drug

Miss One Drug Refill and Face Lifetime Penalty—What to Know

Medicare offers prescription drug coverage through Part D, but the rules behind it can feel like a trap. Many seniors don’t realize that missing just...

Saving Advice

Major Insurers Scale Back Medicare Advantage and Part D Plans for 2026

Beneficiaries enrolled in Medicare Advantage and Part D prescription drug plans might be losing their plan as UnitedHealthcare, Humana, and Aetna (CVS Health) scale back offerings for 2026.

Kiplinger

Moderna Stock Is Rallying Wednesday: What's Driving The Action?

Moderna Inc (NASDAQ:MRNA) stock is trading higher Wednesday afternoon, lifted by positive sentiment across the pharmaceutical sector. The rally follows a landmark agreement Tuesday between Pfizer Inc (NYSE:PFE) and the Trump administration to lower prescription drug prices.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Pfizer agrees to lower prescription drug costs for Medicaid

Under the deal, New York-based Pfizer will charge most-favoured-nation pricing to Medicaid and guarantee that pricing on newly launched drugs, Trump said. That involves matching the lowest price offered in other developed nations.

Euronews

Medicare Beneficiaries To See Slight Premium Decline Next Year

The Centers for Medicare Medicaid Services (CMS) announced on Friday that Medicare Advantage (MA) and Medicare Part D prescription drug program premiums, benefits and plan options are expected to remain largely stable in 2026.

Benzinga

Medicare Part D Caps You Didn’t Know Existed Until Now

Most Medicare users know about deductibles and copays, but fewer realize that Part D prescription drug plans come with several hidden caps that can quietly...

Saving Advice

Will Trump’s Tariffs Spike Your Cost for Prescription Meds? Experts Weigh In

How will Trump's tariffs impact prescription drugs in the U.S.? Let's find out.

GOBankingRates

Read news from The Economist, FT, and more,
with one subscription

Medicare Reforms That Limit Prescription Costs—But Still Leave Gaps You’ll Pay For

For years, prescription drug costs have been one of the biggest financial burdens for seniors. Medicare reforms rolling out in 2025 aim to fix part...

Saving Advice

9 Part D Shopping Tricks That Cut Annual Costs

Prescription drug costs weigh heavily on retirees’ budgets. Medicare Part D offers relief, but choosing the wrong plan can waste hundreds—or even thousands—each year. The...

Saving Advice

8 Medicare Part D Decisions That Change Your Annual Drug Costs Drastically

Prescription drug costs remain one of the biggest worries for retirees. Medicare Part D was designed to help, but the program is full of choices...

Saving Advice

RFK Jr.'s latest 'Make America Healthy Again' report calls for more scrutiny of vaccines and autism

The Trump administration is urging public health agencies to prioritize investigations of vaccine injuries, prescription drug use, and the cause of autism

The Independent UK

Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing

Billionaire entrepreneur Mark Cuban, in a series of posts on the social media platform X early Monday morning, launched a scathing critique of the U.S. prescription drug industry, accusing large wholesalers and Pharmacy Benefit Managers (PBMs) of creating a “stranglehold” on pricing through opaque, anti-competitive practices.

Benzinga

FDA Delays Decision On Agios Pharmaceuticals' Blood Disorder Drug For Expanded Use

On Thursday, the U.S. Food and Drug Administration (FDA) extended the Prescription Drug User Fee Act (PDUFA) goal date for Agios Pharmaceuticals, Inc.’s (NASDAQ:AGIO) supplemental New Drug Application (sNDA) of Pyrukynd (mitapivat) for adult patients with non-transfusion-dependent (NTD) and transfusion-dependent (TD) alpha- or beta-thalassemia by three months to December 7, 2025.

Benzinga

FDA Pushes Back Axogen Avance Nerve Graft Decision By 3 Months

The U.S. Food and Drug Administration (FDA) on Monday extended the Prescription Drug User Fee Act (PDUFA) goal date for Axogen Inc.’s (NASDAQ:AXGN) Biologics License Application (BLA) for Avance Nerve Graft by three months to December 5.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

The Free Financial Advisor

Want to Delay Part D Prescriptions Over Time Instead of Paying Upfront? It Begins Jan 1

High prescription drug costs are one of the biggest burdens retirees face, but a new option is set to bring relief. If you want to delay Part D prescriptions and spread payments out over time instead of paying them all upfront, a change beginning Jan 1 makes it possible. This…

The Free Financial Advisor

Retirees Face $172,500 in Healthcare Costs—And Many Haven’t Saved for It

For many people, retirement planning focuses on housing, leisure, and day-to-day living expenses. But there’s one major cost that catches many off guard — healthcare. Recent estimates show that retirees face $172,500 in healthcare costs—and many haven’t saved for it. That figure covers expenses like Medicare premiums, prescription drugs, and…

Budget and the Bees

8 Costs Retirees Can Stop Paying Today Thanks to New Medicare Changes

Retirement should be a time to enjoy the fruits of your labor. However, for many, managing a fixed income can be a significant source of stress. Healthcare often becomes one of the largest and most unpredictable expenses. Specifically, prescription drug costs pose a particular challenge. Fortunately, recent legislative updates are…

Capital & Main

Reform Refill: Has Scott Wiener Convinced Gov. Newsom to Rein in Prescription Middlemen?

Why a state senator may finally win his battle against powerful pharmacy benefit managers.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

How 340B Drug Discounts Are Driving Up Medicaid Costs By Billions

The rapid expansion of the federal 340B drug pricing program is significantly affecting Medicaid budgets, particularly in states where managed care plans oversee prescription drug benefits.

Clever Dude

Misconceptions About Medicare That Cost Thousands

Navigating Medicare can feel like walking through a maze, especially when myths and half-truths are everywhere. Many people assume Medicare will cover all their health expenses, only to be blindsided by unexpected bills. These misunderstandings can cost retirees and their families thousands of dollars—money that could have been saved or…

Kiplinger

What is the IRMAA (Income-Related Monthly Adjustment Amount)?

IRMAA is a surcharge added to your Medicare Part B and Medicare Part D prescription drug coverage premiums if your income is above a certain level. Here's what you need to know.

The Independent UK

RFK Jr.'s MAHA report raises concerns about vaccines, American foods and prescription drugs

A new government-issued report reflects some of the most controversial views on vaccines, the nation’s food supply, pesticides and prescription drugs held by U.S. Health and Human Services Secretary Robert F

Roll Call

Q&A on Trump’s prescription drug pricing executive order - Roll Call

President Donald Trump said his executive order on drug prices would lower some prices in half or more. But the details are scant.

Reason

Trump Called Price Controls 'Communist.' Now He's Ordering Them for Prescription Drugs.

The president hopes to introduce even more government intervention into health care.

Latin Times

Trump Adviser Called Kamala's Plan to End Price Gouging 'Communist'. Now Trump Plans to End Price Gouging

Former posts where Stephen Miller criticized price controls resurfaced Monday following Trump's latest executive order aimed at cutting prescription drug costs.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.